|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
The over-expression of epidermal growth factor receptor (EGFR) and its ligands, epidermal growth factor (EGF) and transforming growth factor-alpha, is a common feature of epithelial carcinomas and correlates with neoplastic progression.
|
15642791 |
2005 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The EGFR and EGF-like peptides are often over-expressed in human carcinomas, and in vivo and in vitro studies have shown that these proteins are able to induce cell transformation.
|
16377102 |
2006 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Epidermal growth factor (EGF) receptor (EGFR)-mediated motility, present in both autocrine and paracrine modes in prostate carcinomas, requires de novo transcription to persist over times greater than a few hours.
|
16804520 |
2006 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
The human gene Teratocarcinoma-derived growth factor 1 (TDGF1)/Cripto-1/CR-1 which is expressed in a wide variety of human carcinomas is a member of the EGF-cripto FRL1 cryptic (EGF-CFC) gene family.
|
17291450 |
2007 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
EGF is known to affect adherens junctions and disrupt cell-cell adhesion in a variety of carcinomas but the underlying mechanisms are not completely understood.
|
19591825 |
2009 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
EGF promoter polymorphisms are observed to modulate EGF levels and thought to have effect on susceptibility to various carcinomas but the results are inconsistent.
|
20033794 |
2010 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The epidermal growth factor (EGF)-ErbB-mitogen-activated protein kinase (MAPK) transcription signaling pathway is altered in many types of carcinomas, and this pathway can be regulated by new protein-protein interactions.
|
20679487 |
2010 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.
|
21220318 |
2011 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Dlk1, a member of the Epidermal Growth Factor family, is expressed in multiple tissues during development, and has been detected in carcinomas and neuroendocrine tumors.
|
23577150 |
2013 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The EGF receptor (EGFR) is expressed in most cases of anal carcinomas.
|
25244542 |
2015 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The expression of epidermal growth factor (EGF) receptors is common in human carcinomas and the proteins are used as therapeutics targets.
|
29556616 |
2017 |
|
Carcinoma
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
EGF and EGFR are involved in many aspects of the development of carcinomas.
|
28501600 |
2017 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
The human epidermal growth factor (EGF) receptor (HER) family is frequently overexpressed in the majority of human carcinomas, and is involved in promoting the proliferation and survival of cancer cells.
|
30008917 |
2018 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
EGF Level in Hepatoid Gland Adenomas and Hepatoid Gland Epitheliomas in Dogs After Administering Tamoxifen.
|
30150441 |
2018 |